Sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists and cancer mortality. A real-world registry

Back

ESC Professional Premium Access

Sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists and cancer mortality. A real-world registry

Session: Cancer and other risk factors for heart disease

Topic: Pharmacotherapy

Speaker: Doctor D. Garcia Vega (Santiago de Compostela, ES)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor David Garcia Vega

University Hospital of Santiago de Compostela, Santiago de Compostela (Spain)

0 follower

7 more presentations in this session

ABO blood groups and platelet reactivity in patients with coronary artery disease undergoing percutaneous coronary intervention treated with clopidogrel

Speaker: Mrs J. Li (Beijing, CN)

Ischemic and bleeding risk after ST-segment elevated myocardial infarction in patients with active cancer

Speaker: Doctor M. Dafaalla (Keele, GB)

External validation of the Systematic COronary Risk Evaluation 2 (SCORE2) model in cancer patients

Speaker: Mrs M. Gynnild (Trondheim, NO)

Comparison of cardiovascular disease risk assessment tools for heart failure prediction among cancer patients

Speaker: Professor T. Marwick (Melbourne, AU)

Cancer-specific Heart Failure (HF) risk score - a new risk score developed specifically to predict HF among cancer survivors

Speaker: Professor T. Marwick (Melbourne, AU)

Access the full session

Cancer and other risk factors for heart disease

Speakers: Doctor D. Garcia Vega, Mrs J. Li, Doctor M. Dafaalla, Mrs M. Gynnild, Professor T. Marwick...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources